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Shiga toxigenic Escherichia coli (STEC) O157 and several other serogroups of non-O157 STEC are causative agents of severe disease
in humans world-wide. The present study was conducted to characterize STEC O157 and non-O157 serogroups O26, O103, O111,
O121, O45, and O145 in ruminants in Malaysia. A total of 136 ruminant feces samples were collected from 6 different farms in
Peninsular Malaysia. Immunomagnetic beads were used to isolate E. coli O157 and non-O157 serogroups, while PCR was used
for the detection and subtyping of STEC isolates. STEC O157:H7 was isolated from 6 (4%) feces samples and all isolates obtained
carried 𝑠𝑡𝑥2c, eaeA-𝛾1, and ehxA. Non-O157 STEC was isolated from 2 (1.5%) feces samples with one isolate carrying 𝑠𝑡𝑥1a, 𝑠𝑡𝑥2a,
𝑠𝑡𝑥2c, and ehxA and the other carrying 𝑠𝑡𝑥1a alone. The presence of STEC O157 and non-O157 in a small percentage of ruminants
in this study together with their virulence characteristics suggests that they may have limited impact on public health.
1. Introduction
Shiga toxin producing E. coli (STEC), a serologically diverse
group of zoonotic pathogens, have emerged as one of the
most virulent groups of bacteria associated with cases of food
borne disease in humans [1]. STEC can cause a spectrum
of diseases ranging from mild diarrhea to severe bloody
diarrhea, called hemorrhagic colitis (HC), and even life-
threatening sequelae such as hemolytic uremic syndrome
(HUS). Patients with HUS were often diagnosed as hav-
ing thrombotic thrombocytopenic purpura (TTP), although
thrombotic microangiopathy is now considered amore accu-
rate description of the condition associated with HUS caused
by STEC [2]. Production of Shiga toxin (Stx) is considered
as the major virulence factor of STEC [1] which contributes
to the development of HUS in humans [2]. Stx production
alone is not sufficient for STEC to cause disease. Accessory
virulence factors include a 34 kb chromosomal pathogenicity
island called the “locus for enterocyte effacement” (LEE) car-
rying several virulence associated genes, such as the attaching
and effacing (eaeA) gene, and a large plasmid (60MDa) with
an ehxA gene encoding an enterohemolysin. EaeA encodes
an outer-membrane protein called intimin which enables
the intimate adherence of STEC to the intestinal epithelium
of the host [3]. The enterohemolysin protein is implicated in
extracting iron from the blood released into the intestine [4].
The prototype STEC serotype is E. coli O157:H7 and its
ability to cause HC and HUS in many regions and countries
is well established. The pathogenic potential and public
health significance of several non-O157 STEC serogroups,
particularly O26, O103, O111, O121, O145, and O45 referred to
as the “big 6” non-O157 STEC serogroups [5], have also been
described in recent years due to their association with clinical
HC and HUS in humans. In some geographical areas, such as
in Europe, the disease caused by non-O157 strains is signifi-
cantly more common than that caused by O157:H7 [6, 7].
Ruminants are considered an important source of both
E. coli O157 and non-O157 with cattle being identified as the
primary reservoir. Intestinal carriage of E. coliO157 and non-
O157 in ruminants results in their fecal shedding and release
into the environment. As a result, infections of E. coli O157
and non-O157 can be transmitted to humans via the con-
sumption of food and water contaminated by animal feces.
Data on E. coli O157 and non-O157 serotypes in rumi-
nants is limited in countries of the tropical regions including
Malaysia. In addition, the data reported so far on E. coliO157
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Table 1: Distribution of ruminant feces samples collected from farms A–F.
Farm Location Ruminant feces samples Total samples
Cattle Buffalo Goat Sheep
A Serdang 25 — — — 25
B Kluang 9 20 7 8 44
C Sentul 9 — — — 9
D Gemas 24 — — — 24
E Puchong 13 — 5 — 18
F Lumut 16 — — — 16
and non-O157 in ruminants from tropical countries other
than Malaysia demonstrates substantial variation in their
prevalence and virulence properties. In West Bengal, India,
a total of fourteen STEC O157 isolates were obtained from
two (2.04%) slaughtered cattle feces samples and six (7.59%)
diarrhoeic calf feces samples [8]. The majority of STEC O157
isolates (85.71%) obtained from this study carried stx
2
alone.
STECO157 was obtained from 0.6% of cattle feces samples in







alone. The prevalence of
E. coli O157 was found to be 1.25% in cattle farms in central
Mexico [10]. Non-O157 STECwas found in 18% of cattle feces
samples in Calcutta, India [11], in which stx
1
predominated.
In another study in Brazil, non-O157 STEC was isolated from




Only three studies which isolated STEC O157 from
beef samples have to our knowledge been conducted in
Malaysia [13–15]. Apart from a single study which reported
sporadic cases of STECO157 infection among 14% of patients
presented with bloody diarrhea at a local hospital in Kuala
Lumpur, Malaysia [16], there are no other published reports
of sporadic cases or outbreaks of STEC O157 and non-
O157 in the country. Although studies have demonstrated
the presence of STEC O157 in foods of animal origin, the
presence and characterization of STEC O157 or non-O157 in
ruminant feces fromMalaysia has not yet been determined.
The aim of the present study was to examine ruminant
feces samples for the presence of STEC O157 and the “big 6”
non-O157 STEC serogroups in Malaysia. The isolated strains
of E. coli O157 and non-O157 were further characterized to
determine their genetic diversity and presence of virulence
factors to indicate the risk potential of these strains to public
health.
2. Materials and Methods
2.1. Sample Collection and Preparation. Samples were col-
lected from six different ruminant farms in Peninsular
Malaysia (Table 1). The geographical distribution of the six
farms is depicted in Figure 1. Farms A, C, and F were small
dairy cattle farms, while farm E was a small dairy farm
consisting of cattle and goats. Farm B was also a dairy
farm but with a larger number and diversity of ruminants
consisting of cattle, buffaloes, goats, and sheep. Farm D was
a large beef cattle farm. A total of 136 fresh ruminant feces














F. Lumut (n = 16)
C. Sentul (n = 9)
A. Serdang (n = 25)
D. Gemas (n = 24)
E. Puchong
(n = 18)
B. Kluang (n = 44)
N
Total number of samples = 136
Figure 1: Geographical distribution of farms A–F in Peninsular
Malaysia from which the ruminant feces samples were collected.
were collected from the pen floors (over a period of six
months) into sterile containers and were stored at 4∘C on ice
until processed in the lab on the same day. All fecal samples
collected were divided into two 10 g samples. One of the 10 g
samples was used for enrichment and the other was used
for long term storage in tryptone soy broth (TSB; Merck,
Darmstadt, Germany) with 25% glycerol at −70∘C.
2.2. Isolation and Characterization of E. coli O157. Each fecal
sample (10 g) was diluted 1/10 in buffered peptone water
(BPW; Oxoid, Hampshire, UK) and homogenized for 30 s.
Samples were incubated for 18 h at 37∘C without agitation.
Immunomagnetic separation (IMS) was performed using
Dynabeads anti-E. coliO157 (Dynal, Oslo,Norway) according
to the manufacturer’s instructions. Resulting bead-bacteria
complexes were spread on to sorbitol-MacConkey agar
(SMAC; Oxoid, Hampshire, UK) and sorbitol-MacConkey
agar containing the cefixime, tellurite supplement (CT-
SMAC; Oxoid, Hampshire, UK) and incubated for 18 h
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at 37∘C. A total of 10 presumptive E. coli O157 colonies per
sample were serotyped using an E. coli O157 Latex Test Kit
(Oxoid, Hampshire, UK). All isolates agglutinating with the
O157 antiserum were further characterized by polymerase





, eaeA, ehxA, and fliC genes using primers and reaction
conditions as previously described [17].
Characterization of lineage-specific polymorphisms-6
(LSPA-6) of E. coli O157 isolates was performed using target
amplification and capillary electrophoresis as described pre-
viously [18, 19]. AnAppliedBiosystems 3130GeneticAnalyzer
(Applied Biosystems, California, USA) with a DS-33 matrix
and GeneScan 600 LIZsize standard was used for capillary
electrophoresis, while a Peak Scanner software (Version 1.0;
Applied Biosystems, California, USA) was used to interpret
amplicon sizes. LSPA-6 alleles were defined according to [18].
Isolates with LSPA-6 genotype 111111 or 211111 were classified
as lineage I (LI) or lineage I/II (LI/II), respectively, while all
other allele combinations were grouped as lineage II (LII)
[18, 20].
Analysis of Shiga toxin encoding bacteriophage insertion
sites (SBI) of E. coli O157 isolates was determined as previ-
ously described [21].
2.3. Detection, Isolation, and Characterization of Non-O157 E.
coli. Samples (10 g) which were initially stored at −70∘C in
TSB with 25% glycerol were diluted 1/10 in BPW, homog-
enized for 30 s, and incubated for 18 h at 37∘C without
agitation. DNA was extracted from 1mL of the enriched
sample using the Nucleospin Soli DNA extraction kit
(Macherey Nagel, Düren, Germany) following the manufac-
turer’s instructions. A multiplex PCR was used to screen





, eaeA, and ehxA using primers and reaction conditions
as described by A. W. Paton and J. C. Paton [22] with several
modifications. A reaction volume of 25 𝜇L was used with
2 𝜇L of DNA template and final concentration of 0.25𝜇M
of each primer, 5x Green GoTaq Flexi Buffer (Promega,
Madison, USA), 200𝜇M of dNTP, 2mM of MgCl
2
, and 1
unit of GoTaq DNA polymerase (Promega, Madison, USA).
The PCR products were separated by electrophoresis on a
2% agarose gel, stained with ethidium bromide (0.5𝜇g/mL)
and visualized under UV light. Enriched samples positive
for stx and eaeA by PCR were streaked on chromocult-
TBX agar (Merck, Darmstadt, Germany) and coliformen
agar enhanced selectivity (Merck, Darmstadt, Germany) and
incubated overnight at 37∘C. Following incubation, up to 50
E. coli colonies per sample were chosen based on colony
morphology and screened individually by multiplex PCR for




, eaeA, and ehxA as described above.
Colonies that were positive for stx and eaeA were then tested
for the “big 6” E. coli non-O157 serogroups by PCR using
primers and conditions described previously [17, 23].
The enriched samples were also tested for the presence
of genes specific to the “big 6” E. coli non-O157 sero-
groups. Samples that tested positive by PCR for any of the
target serogroups were subjected to IMS for O26, O111,
O103, and O145 using Dynabeads (Dynal, Oslo, Norway)
following the manufacturer’s instructions. The bead-bacteria
complexes formed during IMS of O26 were plated onto
rhamnose MacConkey agar, while those of O111, O103, and
O145 were plated onto chromocult-TBX agar and coliformen
agar-enhanced selectivity and incubated overnight at 37∘C.
Following incubation, 10 presumptive colonies (per sample)
based on colony morphology were subjected to serogroup
specific PCR and those confirmed as a specific serogroup
were tested by PCR for the presence of STEC virulence genes.
Isolation of serogroups O45 and O121 was performed on
enriched fecal samples positive for STEC virulence markers
which were directly plated onto chromocult-TBX agar as
described above.
2.4. Biochemical Confirmation of E. coli Isolates. All the
isolates were biochemically identified as E. coli by citrate
utilization and indole production tests [24].
2.5. Bacterial Strains. Thebacterial strains used as controls in
this study are listed in Table 2.
2.6. Pulsed-Field Gel Electrophoresis (PFGE). PFGE using
XbaI was performed on all E. coliO157 and non-O157 isolates
in a CHEF Mapper (Bio-Rad, California, USA) according
to the standardized PulseNet protocol [25]. Banding pat-
terns were analysed using BioNumerics software, version
6.5 (Applied Maths BVBA, Sint-Martens-Latem, Belgium)
following the PulseNet protocol.
2.7. Subtyping of stx and Intimin (eaeA) Genes of E. coli O157
and Non-O157. The subtypes of stx and eaeA in isolates
carrying thesemarkers were determined following previously
published methods [26, 27].
2.8. Detection of Shiga Toxin Expression. Stx expression by
the STEC strains was determined according to the method
adapted from Shringi et al. [28] using an ELISA kit (Premier
EHEC, Meridian Bioscience, Ohio, USA). Mitomycin C
(Sigma Aldrich, Missouri, USA) was used at a final concen-
tration of 0.5 𝜇g/mL to induce Stx production. After induc-
tion, the cells were lysed using Polymixin B (Sigma Aldrich,
Missouri, USA) at a final concentration of 0.5mg/mL and
incubated at 37∘C for 1 h with rotary shaking (250 rpm).
Polymixin B treated cultures were diluted 1 : 100 in sterile LB
broth immediately followed by 1 : 2 dilution in sample diluent
of the ELISA kit. Absorbance readings were obtained at
wavelengths 450 nm and 630 nm using a Victor X microtiter
plate reader (Perkin Elmer, GlenWaverley, Australia) and the
results were displayed as the mean value of two independent
biological replicates.
3. Results
3.1. Presence of STEC O157 and Virulence Factors. STEC
O157 was isolated from 6 (4%) cattle feces samples, all of
which were from farm A (Table 3). A total of 32 STEC O157
isolates were obtained from 6 different cattle feces samples.
The isolates obtained were clustered into two different PFGE
groups (at >92% similarity) with the majority of isolates (28
isolates from5different fecal samples) belonging to onePFGE
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Table 2: Bacterial strains used in the study.
Strain ID Serogroup Source Country Virulence traits















EC6a O157 Cattle feces Australia 𝑠𝑡𝑥
2
, eaeA, ehxA




















MG1655 (E. coli K-12) OR:H48:K-b Laboratory strain USA None
EC3008ac O26 Cattle feces Australia eaeA
EC3009ac O45 Cattle feces Australia None
EC2998ac O103 Cattle feces Australia None
EC3113ac O111 Cattle feces Australia None
EC3111ac O121 Cattle feces Australia None
aProvided by Professor Son Radu at Universiti Putra Malaysia.
bOR = O antigen rough strain which does not produce a typeable O antigen.
c
𝐸. coli non-O157 strains used as controls in the study, provided by Lesley Duffy at CSIRO, Brisbane, Australia.
Table 3: STEC O157 and non-O157 and their virulence profiles.




factors Lineage SBI profile
O157:H7a
6 (4%) Cattle feces 28
b 𝑠𝑡𝑥2c, eaeA-𝛾1,
ehxA II SY2c
4b 𝑠𝑡𝑥2c, eaeA-𝛾1ehxA II SY2c
Non-O157a







aIsolates of STEC O157:H7 and non-O157 were only present in samples obtained from farm A. All samples from farms B–F were negative for STEC O157:H7
and non-O157 isolates.
bOn farm A, 28 of the STEC O157 isolates belonged to one PFGE group (at >92% similarity) and the remaining 4 isolates belonged to another PFGE group.
—: not applicable.
group and the remaining isolates (4 isolates froma single fecal
sample) belonging to the other. All 32 STEC O157 isolates
were positive for the virulence factors stx
2
, eaeA, and ehxA
and also for fliC specific for the H7 antigen indicating they
belong to the O157:H7 genotype. All samples from farms B–F
were negative for the presence STEC O157.
LSPA-6 target amplification indicated that all the STEC
O157:H7 isolates collected from cattle feces samples in farm
A belong to lineage II (Table 3). According to the SBI
genotyping code, genotype SY2c was observed in all STEC
O157:H7 isolates collected from cattle feces samples in farm
A indicating the association of 𝑠𝑡𝑥
2c with prophage insertion
in the sbcB locus (Table 3).
In addition, all STEC O157:H7 isolates obtained from




, eaeA, and ehxA
and belonged to a single PFGE group (at >92% similarity).
They were of lineage I and contained the SBI genotypeWY12




insertion in the yehV and wrbA loci, respectively.
3.2. Presence of Non-O157 STEC and Virulence Factors. In
the initial PCR screen of the enriched samples, various
combinations of virulence markers and genes for the target
non-O157 serogroups were observed in all the farms except in
farm F. Although samples in farm Fwere positive for different
combinations of virulence markers, none of the samples were
positive for any of the target non-O157 serogroups tested





both) and eaeA was present in 32.3% (44 samples out of 136
samples), while the gene indicating the presence of serogroup
O103 seemed to be predominant (44.1%of samples) among all
136 samples.
Although the initial PCR screening of the enriched feces
samples indicated a relatively high number of samples with
the target genes for the virulence factors and non-O157
serogroups, only 2 samples (1.5%) yielded non-O157 STEC
isolates (Table 3). Both of these were cattle feces samples
collected from farm A, from which two non-O157 STEC
strains (negative for any of the “big 6” non-O157 serogroups)
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Table 5: Isolation and virulence profiles of E. coli O157 and “big 6” E. coli non-O157 serogroups lacking stx.
Serogroup Farm Source Number of +samples
Number of
isolates tested Virulence factors
Intimin
subtype
O103 A Cattle feces 3 3 None —
O157 B
Cattle feces 1 2 eaeA NTa
Sheep feces 2 3 eaeA (1 isolate)none (2 isolates) NT
Buffalo feces 3 5 eaeA NT





O103 B Buffalo feces 1 7 None —
O26 C Cattle feces 2 11 None —
aNT = non-typable.
—: not applicable.
were isolated which belonged to two unique PFGE groups.





, and ehxA while the other isolate was positive for stx
1
alone.
3.3. Characterization of E. coli Serogroups Lacking stx. E. coli
of the target serogroups (O157 and the “big 6” non-O157)
lacking stx but carrying other combinations of virulence
markers were also isolated from ruminant feces samples
(Table 5).These includedE. coli of serogroupsO157,O103, and
O26 which were negative for any of the virulence markers,
O157 which carried eaeA alone and O26 with eaeA and ehxA.
3.4. stx and eaeA Subtyping. All the STEC O157:H7 isolates
collected from cattle feces samples in farmAwere positive for
𝑠𝑡𝑥
2c (Table 3), while all STEC O157:H7 isolates from UPM
were positive for 𝑠𝑡𝑥
1a and 𝑠𝑡𝑥2a. One of the non-O157 STEC
isolates was positive for 𝑠𝑡𝑥
1a, 𝑠𝑡𝑥2a, and 𝑠𝑡𝑥2c, while the other
isolate was positive for 𝑠𝑡𝑥
1a alone (Table 3). Overall, 𝑠𝑡𝑥2c




Two different eaeA subtypes out of the seven eaeA
variants (𝛼1, 𝛼2, 𝛽1, 𝛽2, 𝛾1, 𝛾2/𝜃, and 𝜀) tested were present
among the eaeA positive isolates of E. coli O157 and non-
O157. The STEC O157:H7 isolates were positive for eaeA-𝛾1
(Table 3) while the two O26 isolates lacking stx were positive
for eaeA-𝛽1 (Table 5).
3.5. Shiga Toxin Production. Stx production of all the 𝑠𝑡𝑥
2c
positive STEC O157:H7 isolates collected from the cattle
feces samples in farm A were below the level of detection.
In contrast, all the 𝑠𝑡𝑥
1a and 𝑠𝑡𝑥2a positive STEC O157:H7
isolates obtained from UPM produced a high amount of
Stx similar to the positive control STEC O157:H7 isolates,
ATCC 43895, EC543a, and EC6a. Of the two non-O157 STEC
isolates, Stx production of the 𝑠𝑡𝑥
1a positive non-O157 isolate
was also below the level of detection. However, the 𝑠𝑡𝑥
1a,
𝑠𝑡𝑥
2a, and 𝑠𝑡𝑥2c positive non-O157 STEC isolate indicated a
moderate amount of Stx production although lower than that
observed for the UPM STEC O157:H7 isolates.
4. Discussion
In Malaysia, no studies have been conducted so far to
characterize STEC O157 or non-O157 in ruminant feces.
Thus, the goal of the present study was to gain insight on the
virulence determinants of STEC O157 and non-O157 present
in ruminant feces in Malaysia.
In this study, STEC O157 was isolated from 6 (4.4%)
ruminant feces samples and non-O157 STEC was isolated
from 2 (1.5%) of the ruminant feces samples. Several other
authors have also reported low isolation rates (less than 10%)
of STEC O157 and non-O157 in ruminant feces in tropical
countries [8, 12]. However, this study was not adequate to
determine the prevalence of STEC O157 and non-O157 in
Malaysia and, thus, to obtain more comprehensive data on
the prevalence of STEC O157 and non-O157 serogroups
in Malaysia, sampling of a wider geographical area within
Malaysia should be undertaken.
E. coliO157 populations have been shown to vary in their
distribution among bovine and clinical sources due to their
genotypic differences [29]. LSPA-6 analysis, a simple multi-
plex PCR assay, categorizes E. coliO157 strains into three dif-
ferent genotypes referred to as lineage I, lineage I/II, and lin-
eage II. Isolates of lineage I and I/II aremostly associated with
human clinical sources while lineage II isolates are mostly
associatedwith bovine sources [18]. In this study, all the STEC
O157:H7 isolates belonged to lineage II in contrast to STEC
O157 isolates fromcountries such asAustralia andUSAwhere
lineage I/II and lineage I predominates [30]. Interestingly,
all the STEC O157:H7 isolates from UPM were of lineage I
indicating the presence of STECO157 isolates of both lineage
I and II in bovine sources in Malaysia. STEC O157 isolates of
lineage II are shown to be less virulent and possibly impaired
in their transmissibility to humans compared to lineage I or
I/II [31]. The presence of STEC O157 isolates of lineage II
in ruminants in Malaysia from this study suggests that these
isolates could have less pathogenic potential in humans.
Pathogenic potential of STEC isolates has also been
shown to be associated with the presence of particular stx




with low virulence potential compared to those which carry




2a) [32]. In this study, all the STEC O157:H7 isolates
obtained carried 𝑠𝑡𝑥
2c indicating low virulence potential in
humans compared to the STEC O157:H7 isolates from UPM
with 𝑠𝑡𝑥
1a and 𝑠𝑡𝑥2a. One of the two non-O157 STEC isolates
of unknown serogroupwith 𝑠𝑡𝑥
1a, 𝑠𝑡𝑥2a, and 𝑠𝑡𝑥2c indicated a
high pathogenic potential compared to the other isolate with
𝑠𝑡𝑥
1a alone.
Not all E. coli isolates carrying stx produce Stx [33]. This
was true for all 𝑠𝑡𝑥
2c positive STEC O157:H7 isolates and one
of the non-O157 isolates positive for 𝑠𝑡𝑥
1a obtained in this
study. In contrast, theUPMSTECO157 isolates produced Stx.
Although the exact reasons for the discrepancy observed in
Stx production of stx positive E. coli isolates from this study
is not fully understood, previous studies have also identified
E. coli isolates positive for stx but negative for Stx production
[33, 34]. In fact, the study by Koitabashi et al. [34] suggested
that stx
2
positive E. coli O157 strains that produce little or no
Stx2 may be widely distributed in the Asian environment.
Particular stx genotypes of STEC O157 have been shown
to be associated both with particular SBI genotypes and with
their relative frequency of isolation from clinical and bovine
sources [21]. Clinical isolates are generally characterized





sequences adjacent to either wrbA or argW (SBI genotypes:
WY12, AY2, ASY2, ASY22c), while bovine isolates are char-
acterized by carrying of 𝑠𝑡𝑥
2c and 𝑠𝑡𝑥2c-associated bacte-
riophage sequences adjacent to sbcB (SBI genotypes: SY2c,
SY12c, and ASY12c). In agreement with these observations,
the STEC O157 isolates obtained from cattle feces from this
study carried 𝑠𝑡𝑥
2c with an occupied sbcB locus (SY2c).
However, the STEC O157 from UPM which were collected
from bovine sources carried stx
2
and an occupiedwrbA locus
indicating characteristics of clinical isolates.
All the STECO157:H7 isolates in this study and the STEC
O157:H7 isolates from UPM carried eaeA-𝛾1 as reported for
eaeA positive E. coli O157 in previous studies [27, 35]. None
of the eaeA positive non-STECO157 could be subtyped using
the primers for eaeA subtypes 𝛼1, 𝛼2, 𝛽1, 𝛽2, 𝛾1, 𝛾2/𝜃, and
𝜀. It is possible that these isolates belonged to other intimin
subtypes such as 𝛿/𝜅, 𝜁, 𝜂, 𝜄, 𝜆, 𝜇, and ] which were not tested
for in this study. The two eaeA positive E. coli O26 isolates
carried eaeA-𝛽1 similar to several other E. coli O26 isolates
previously associated with human STEC strains that cause
HUS [27].
5. Conclusions
Despite the use of specific and sensitive methods of enrich-
ment and IMS followed in this study to isolate STEC O157
and non-O157, it appears that the presence of both STECO157
and non-O157 in ruminant feces was low (4% and 1.5%, resp.).
The 𝑠𝑡𝑥
2c carrying STEC O157:H7 isolates of lineage II from
this study suggests that these bacteria potentially represent a
less pathogenic clone of STECO157 inMalaysia.This together
with the presence of STEC O157 and non-O157 in a small
percentage of ruminants in this study could contribute to the
reasons for the lack of reported sporadic cases and outbreaks
caused by STEC O157 in Malaysia. Similar to STEC O157, the
low percentage of non-O157 STEC isolates observed together
with their low pathogenic potential indicated by the lack
of eaeA and moderate to no Stx production suggests a low
probability of causing disease in humans.
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